AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020
March 10 2020 - 4:01PM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of
innovative, minimally invasive medical devices for vascular access,
peripheral vascular disease, and oncology, today announced that it
will report financial results for the third quarter of fiscal year
2020 before the market open on Tuesday, April 7, 2020. The
Company’s management will host a conference call at 8:00 a.m. ET
the same day to discuss the results.
To participate in the conference call, dial 1-877-407-0784
(domestic) or +1-201-689-8560 (international) and refer to the
passcode 13700177.
This conference call will also be webcast and can be accessed
from the “Investors” section of the AngioDynamics website at
www.angiodynamics.com. The webcast replay of the call will be
available at the same site approximately one hour after the end of
the call.
A recording of the call will also be available from 11:00 a.m.
ET on Tuesday, April 7, 2020, until 11:59 p.m. ET on Tuesday, April
14, 2020. To hear this recording, dial 1-844-512-2921 (domestic) or
+1-412-317-6671 (international) and enter the passcode
13700177.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative,
minimally invasive medical devices used by professional healthcare
providers for vascular access, peripheral vascular disease, and
oncology. AngioDynamics’ diverse product lines include
market-leading ablation systems, vascular access products,
angiographic products and accessories, drainage products,
thrombolytic products and venous products. For more information,
visit www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200310005809/en/
Investors: AngioDynamics, Inc. Stephen Trowbridge, Executive
Vice President & CFO (518) 795-1408
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Apr 2023 to Apr 2024